Guardian touts CAD clinical results

Radiology informatics firm Guardian Technologies International has completed a clinical study involving the evaluation of its Signature Mapping software with an online database of mammographic x-ray exams, known as the Digital Database for Screening Mammography (DDSM) project.

The Herndon, VA, company said Signature Mapping achieved 97% sensitivity on cancer cases, with 3% false negatives. With noncancer cases, Signature Mapping specified no cancer in 99% of the images, with a false-positive rate of 1%.

Guardian's study analyzed 160 images from 40 normal cases, and 80 images from 40 cancer cases.

By AuntMinnie.com staff writers
July 16, 2007

Related Reading

Guardian files patent for CAD algorithm, June 25, 2007

Confirma, Guardian partner on CAD, April 26, 2007

Guardian completes clinical test of CAD algorithm, March 16, 2007

Road to RSNA, Guardian Technologies International, November 7, 2006

Road to RSNA, Guardian Technologies International, November 3, 2006

Copyright © 2007 AuntMinnie.com

Page 1 of 371
Next Page